What's in Hadassah Medical Organization's pipeline?

Hadassah Medical Organization has 74 drugs in our index: 25 marketed, 0 filed, 5 in Phase 3, 7 in Phase 2, 37 in Phase 1.

Which companies overlap with Hadassah Medical Organization's portfolio?

Top competitors by shared drug class: Air Force Military Medical University, China, Pfizer, Procter and Gamble, Sanofi, Active Biotech AB.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/hadassah-medical-organization.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Hadassah Medical Organization — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hadassah Medical Organization pipeline: 25 marketed, 0 filed, 5 Phase 3, 7 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

25 marketed 0 filed 5 Phase 3 7 Phase 2 37 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Dextrose 50	Dextrose 50	marketed
Femarelle	Femarelle	marketed			Other
Epidural lidocaine	Epidural lidocaine	marketed
discontinuation of aspirin therapy	discontinuation of aspirin therapy	marketed
Epidural Steroid Injection	Epidural Steroid Injection	marketed
mifepristone and oxytocin	mifepristone and oxytocin	marketed
continuation of aspirin therapy	continuation of aspirin therapy	marketed
Sambucol	Sambucol	marketed			Other
Bupivacaine epidural	Bupivacaine epidural	marketed
Acyclovir 5%	Acyclovir 5%	marketed
Debrisoquin	Debrisoquine	marketed	debrisoquine	Amine oxidase [flavin-containing] A, Amine oxidase [flavin-containing] B	Neuroscience
Sugammadex Reversal	Sugammadex Reversal	marketed

Therapeutic area mix

Other · 8
Immunology · 3
Oncology · 2
Neurology, Cognitive Enhancement, Nutritional Supplement · 1
Neuroscience · 1
Obstetrics · 1
Orthopedics / Musculoskeletal · 1
Pain management, Neurology · 1
Reproductive Health / Obstetrics · 1
Toxicology / Emergency Medicine · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Air Force Military Medical University, China · 3 shared drug classes
Pfizer · 2 shared drug classes
Procter and Gamble · 2 shared drug classes
Sanofi · 2 shared drug classes
Active Biotech AB · 1 shared drug class
Allakos Inc. · 1 shared drug class
Ain Shams University · 1 shared drug class
Allergan · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Hadassah Medical Organization:

Cite this brief

Drug Landscape (2026). Hadassah Medical Organization — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/hadassah-medical-organization. Accessed 2026-05-17.